natgillin/translations-raw huggingface dataset:
A fluid distribution system according to claim 14 when dependent on claim 12, wherein said second fluid inlet to said pilot valve arrangement is fluidly connected to said intermediate line. 
Sustav (10004) za distribuciju fluida prema zahtjevu 14 kada ovisi o zahtjevu 12, pri čemu je navedeni drugi dovod (122) fluida do navedenog sklopa (301, 1011a) pilot ventila fluidno povezan s navedenom srednjom linijom
Advantageously, in cases in which in the forming chamber 1 there is a forming mandrel 13 (and, in particular, in cases involving activation of the sub-step of enriching the process air with pressurised nebulised water), before being introduced into the forming mandrel 13, the process air is subjected to a condensate separation process to eliminate any water present in the process air. 
Postupak oblikovanja prema zahtjevu 18 kada ovisi, izravno ili neizravno, o zahtjevu 15, naznačen time da je, prije nego što se uvodi u rog za oblikovanje (13), zrak za postupak podvrgnut postupku odvajanja kondenzata za uklanjanje sve vode koja se nalazi u zraku za postupak.
The beverage production device according to any of the preceding claims, wherein the evacuating outlet (12, 13) is located at a lower position than the inlet side of the thermoblock (3, 4). 
(14) vruće vode istodobno iz dva termobloka (3, 4) kada niti jedna od komora za kuhanje (5, 6) ne dobiva vruću vođu iz bilo kojeg od termoblokova (3, 4).
an antibody or a fragment thereof which specifically binds to said activated HGF B chain; or 
(b) antitijelo ili njegov fragment koji se specifično veže na spomenuti aktivirani HGF (lanac; ili
Ultimately, the quantity of compound administered will be commensurate with the nature of the disease or physiological condition being treated and the therapeutic benefits and the presence or absence of side effects produced by a given dosage regimen, and will be at the discretion of the physician. 
Konačno, količina primijenjenog spoja će biti razmjerna prirodi oboljenja ili fiziološkog stanja koje treba tretirati kao i o terapeutskoj dobrobiti i prisutnosti ili odsutnosti nuz-djelovanja izazvanih dozirnim režimom, a određuje ju liječnik.
(ii) at least one light chain variable region, said light chain variable region comprising: 
najmanje jednu varijabilnu regiju lakog lanca, spomenuta varijabilna regija lakog lanca obuhvaća:
In a particularly preferred embodiment of the process of the present invention the compound of formula (IX) is further converted to a compound of formula (X) 
Postupak u skladu s patentnim zahtjevom 14, naznačen time što spoj formule (IX) se prevodi u spoj formule (X)
The method of claim 3, wherein the mixed mode resin is Capto™ Adhere and steps (a) and (b) are conducted at a pH of about 4.5 to about 8.5; and said salt solution optionally further comprises arginine. 
Postupak sukladno zahtjevu 3, pri čemu je mešovita smola Capto"" Adhere i koraci (a) i (b) se izvode na pH od oko 4.5 do oko 8.5; navedena otopina soli opcionalno nadalje sadrži arginin.
is C1-2-alkyl, wherein said C1-2-alkyl is substituted with -SO3H or -CO2H; or a pharmaceutically acceptable salt, a stereoisomer, a mixture of stereoisomers, or a tautomer thereof. 
je C1-2-alkil, pri čemu spomenuti C1-2-alkil je supstituiran sa-SO3H ili -CO2H; ili njegova farmaceutski prihvatljiva sol, stereoizomer, mješavina stereoizomera, ili njegov tautomer.
A tablet according to claim 8, wherein the molecular weight of said high molecular weight PEO is at least one of 4 million and 7 million. 
najmanje jedan polietilen oksid koji ima, prema reološkim mjerenjima, približnu molekularnu težinu od najmanje 1,000,000; te
The shipping container of claim 1 wherein secondary sidewalls (100) are in a vertical position when the secondary sidewalls (100) are pivoted to their upright positions. 
Transportni spremnik sukladno patentnom zahtjevu 1 pri čemu su sekundarne bočne stijenke (100) u okomitom položaju kada se sekundarne bočne stijenke (100) zakreću u svoje okomite položaje.
The process of claim 9, wherein the nonwoven fabric is formed by collecting the fibers on a surface or carrier. 
Postupak prema zahtjevu 7, naznačen time da se netkani materijal oblikuje prikupljanjem vlakana na površini ili nosaču.
The method of claims 1-35, wherein the saccharide is a bacterial capsular saccharide, for instance derived from a bacterium selected from a list consisting of: N. meningitidis serogroup A, B, C, W135 or Y, Streptococcus pneumoniae serotypes 1, 2, 3, 4, 5, 6A, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F or 33F, Group B Streptococcus group Ia, Ib, II, III, IV, V, VI, or VII, Staphylococcus aureus type 5, Staphylococcus aureus type 8, Salmonella typhi (Vi saccharide), Vibrio cholerae, or H. influenzae type b. 
Imunogeni pripravak u skladu s bilo kojim od prethodnih patentnih zahtjeva, naznačen time što sadrži vezikularni pripravak vanjske membrane bakterije N. meningitidis seroskupina B. Imunogeni pripravak u skladu s bilo kojim od prethodnih patentnih zahtjeva, naznačen time što najmanje dva dodatna konjugata bakterijskih saharida sadrže saharid iz kapsule bakterije S. pneumoniae kojeg se dobiva iz soja kojeg se bira iz skupine koju čine serotipovi 1, 2, 3, 4, 5, 6A, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F i 33F.
Another embodiment is distinctive due to the fact that the first coupling elements are respectively provided in the form of a left-hand and a right-hand design. 
Zaštitna kaciga (2) prema zahtjevu 1 ili 2, naznačena time da su prvi spojni elementi (7) zasebno formirani u obliku lijevostrane i desnostrane izvedbe.
According to the prior art, separation by mechanical machining is effected in particular by sawing with a circular saw, preferably with a diamond circular saw which is operated at high speed. 
Prema stanju tehnike, odvajanje mehaničkom strojnom obradom vrši se posebno pomoću kružne pile, ponajprije s dijamantnom kružnom pilom koja radi pri velikoj brzini.
A process according to claim 1 wherein the epoxidization is carried out by reacting a compound of formula III with alkaline alkoxides or hydroxides in the presence of alcoholic solvents or ethers optionally in admixture. 
Postupak prema zahtjevu 1 gdje se epoksidacija provodi reakcijom spoja formule III s alkalnim alkoksidima ili hidroksidima u prisutnosti alkoholnih otapala ili etera po izboru u smjesi.
In another aspect, the crenolanib or a salt thereof is administered orally, intravenously, or intraperitoneally. 
Pripravak namijenjen uporabi u skladu s patentnim zahtjevom 13, pri čemu se crenolanib ili njegova sol daju oralno, intravenozno ili intraperitonealno.
The portable sewage water treatment system of Claim 1 wherein said select angle is no greater than 29° (29 degrees). 
Prijenosan sustav za pročišćavanje otpadnih voda prema zahtjevu 1, pri čemu naveden određen kut nije veći od 29 * (29 stupnjeva).
Applying ultrasound to a filler-based resin makes the filler particles move and thereby letting the particle find the optimal packing in the cavity. 
Primjenom ultrazvuka na bazu za smolu, pomiču se čestice punila i time se ostavlja česticama HR P20080380 T3 da nađu optimalno pakiranje šupljine.
respective panels located under the side sections making up the small side walls (Pf) or side closures of the tunnel with the lower footings, which articulate by collapsing towards the inside of the tunnel for facilitating the transport and stripping operations, being operated by a cylinder or similar means (7). 
Cc) odgovarajući paneli koji se nalaze ispod bočnih odjeljaka koji čine male bočne stjenke (PA) ili bočni zatvarači tunela s donjim pragovima, uzglobljenim slijeganjem prema unutrašnjosti tunela kako bi se olakšalo radnje transporta i skidanja, što se provodi uz pomoć cilindara ili na slične načine (7).
The resulting crude is purified by chromatography on silica eluting with ethyl acetate/iso-hexane (1:8 increasing to 1:4) to yield the product which was further purified by trituration with ethyl acetate/iso-hexane to afford the titled product. 
Dobiveni sirov proizvod sc očisti kromatografijom na silika gelu ispirući s etil acetat/izo-heksanom (1:8 rastući do 1:4), čime se dobije proizvod koji se dalje očisti s trituriranjem s etil acetat/izo-heksanom, čime se dobije naslovni proizvod.
The guiding element according to one or more of the preceding claims, characterized in that it comprises end blocks which are shaped complementarily to the shape of a respective unit (2, 3) and are provided with retention means (19) for a respective end of said lamina (4). 
Element za vođenje u skladu s jednim ili više prethodnih patentnih zahtjeva, naznačen time, da obuhvaća završne blokove koji su komplementarni s oblikom odgovarajuće jedinice (2, 3) i opremljeni su sredstvima za zadržavanje (19) za odgovarajući kraj navedene lamele (4).
A process for making a chewable product, said process comprising: providing a heated and liquefied honey, wherein the heated and liquefied honey is obtained by: 
Proces za pravljenje proizvoda za žvakanje, navedeni proces koji sadrži: a) = osiguravanje zagrijanog i tekućeg meda, pri čemu se zagrijani i tekući med dobiva: i)
In further embodiments, the antigen comprises at least a portion of an autoimmune antigen, an antigen expressed on a tissue to be transplanted into a subject, or an allergen. 
Spoj sukladno zahtjevu 1, pri čemu spomenuti antigen sadrži autoimuni antigen, antigen izražen na tkivu koje treba transplantirati u subjekta, ili alergen.
The closure wall normally extends across the mouth opening of the vial. 
Stijenka zatvarača se normalno prostire po cijelom ulaznom otvoru bočice.
The oral controlled release pharmaceutical composition according to claim 6, wherein lubricant is one or more selected from magnesium, aluminium, zinc or calcium stearate, sodium stearyl fumarate, polyethylene glycol, mineral oil, stearic acid, hydrogenated vegetable oil, glyceryl behenate, glyceryl palmitostearate, glyceryl stearate, cornstarch, talc, calcium silicate, magnesium silicate, colloidal silicondioxide, silicon hydrogel, or mixtures thereof. 
Oralni farmaceutski pripravak s kontroliranim oslobađanjem u skladu sa zahtjevom 8, naznačen time da je sredstvo za podmazivanje jedno ili više njih, odabranih između magnezijevog, aluminijevog, cinkovog ili kalcijevog stearata, natrij stearil fumarata, polietilen glikola, mineralnog ulja, stearinske kiseline, hidrogeniziranog biljnog ulja, gliceril behenata, gliceril palmitostearata, gliceril stearata, kukuruznog škroba, talka, kalcijevog silikata, magnezijevog silikata, koloidnog silicijevog dioksida, silicijevog hidrogela ili mješavina istih.
Device according to any one of claims 35 to 39, characterized in that said equipment (65) for the application of an adhesive (20) has a plurality of nozzles for the application of said adhesive (20). 
Uređaj u skladu s bilo kojim od patentnih zahtjeva 29 do 33, naznačen time, što navedena oprema (65) za nanošenje ljepila (20) ima veći broj mlaznica za nanošenje navedenog ljepila (20).
The host cell according to claim 23, wherein the host cell is bacteria, preferably E. coli. 
Stanica domaćin sukladno patentnom zahtjevu 9, pri čemu je stanica domaćin bakterija.
and R9 can together form a 4, 5, 6, or 7 membered heterocyclyl ring or a 5 or 6 membered heteroaryl ring; m is a single bond; and n is a double bond. 
RiR? mogu zajedno tvoriti heterociklički prsten od 4, 5, 6 ili 7 članova ili heteroarilni prsten od 5 ili 6 članova; m jejednostruka veza; i n je dvostruka veza.
when the hair-dryer 16 is supplied, it is possible to perform cyclically test measures as in phases V and VI, to ascertain good working of the GFCI 1. 
kad je sušilo za kosu 16 napajano, moguće je ciklički provesti testiranje kao u fazama V i VI, kako bi se provjerio ispravan rad GFCI 1.
The receiver (2) receives solar radiation (1) by reflection on the internal surface of the paraboloid, given that said receiver (2) is located at the focus of the parabolic dish (10), and oriented towards the paraboloid. 
Prijamnik (2) sunčevog zračenja (1) prema bilo kojem od prethodnih zahtjeva naznačen time što prijamnik (2) ima oblik kružne ili kružne djelomične geometrije.
The material handler of Claim 6, wherein the indentations have a diameter in the range of 200µm to 400µm and a depth relative to the apex of the peripheral lip in the range of 0.5µm to 2.0µm. 
Jedinica za rukovanje prema zahtjevu 6, naznačena time što udubljenja imaju promjer u rasponu od 200 µm do 400 µm i dubinu u odnosu na vrh periferne usne u rasponu od 0.5 µm do 2.0 µm.
The transdermal delivery device of claim 1, wherein the drug containing layer is a matrix layer, and the matrix preferably comprises a material selected from the group consisting of polyethylene, polypropylene, ethylene/propylene copolymers, ethylene/ethylacrylate copolymers, ethylenevinyl acetate copolymers, silicones, rubber, rubber-like synthetic homo-, co- or block polymers, polyacrylic esters and the copolymers thereof, polyurethanes, polyisobutylene, chlorinated polyethylene, polyvinylchloride, vinyl chloride-vinyl acetate copolymer, polymethacrylate polymer (hydrogel), polyvinylidene chloride, poly(ethylene terephthalate), ethylene-vinyl alcohol copolymer, ethylene-vinyloxyethanol copolymer, silicones (e.g., silicone copolymers such as polysiloxane-polymethacrylate copolymers), cellulose polymers (e.g., ethyl cellulose, and cellulose esters), polycarbonates, polytetrafluoroethylene and mixtures thereof. 
Uređaj za transdermalno davanje prema bilo kojem od zahtjeva 1 do 4, naznačen time da sloj polimerne matrice sadrži materijal odabran iz skupine koju čine polietilen, polipropilen, kopolimeri etilen/propilen, etilen/etilakrilat kopolimeri, kopolimeri etilenvinil acetat, silikoni, guma, gumasti sintetski homopolimeri, kopolimeri ili blok polimeri, poliakrilni esteri i njihovi kopolimeri, poliuretani, poliizobutilen, klorirani polietilen, polivinilklorid, vinil klorid-vinil acetat kopolimer, polimetakrilatni polimer (hidrogel), poliviniliden klorid, poli(etilen tereftalat), kopolimer etilen-vinil alkohol, kopolimer etilen-viniloksietanol, silikoni (npr., silikonski kopolimeri kao kopolimeri polisiloksan-polimetakrilat), celulozni polimeri (npr., etil celuloza, i celulozni esteri), polikarbonati, politetrafluoretilen i njihove smjese.
x varying from 2 to 3, y varying from 0 to 0.5 and y being other than 0, 
xvariraod 2 do 3, - - y varira od 0 do 0.5 i y je različit od 0, -
Another embodiment is that said antibody is the antibody that is obtained from the deposited cell line DSM ACC2939. 
Protutijelo, naznačeno time, da se dobiva iz stanične linije DSM ACC2939.
Preferentially, the containers according to the present invention are selected from the group consisting of cans, cans of food, glass jars, cardboard boxes of the carton or Tetrapack® type. 
Ambalažno pakiranje (1) u skladu s bilo kojim od prethodnih zahtjeva, naznačeno time da su navedeni spremnici (2) odabrani iz skupine koja se sastoji od limenki, konzervi, staklenki, kartonskih kutija tetraedarskog tipa ili tetrapaka Đ.
The composition of claim 1, wherein 19% to 28% of the polypeptides in the mixture have diethylamide at one end thereof. 
Sastav prema bilo kojem od patentnih zahtjeva 1 - 4, naznačen time, da 19% do 28% polipeptida u smjesi imaju dietilamid na jednom njihovom kraju.
A device (100; 100') according to claims 3 or 4, wherein the edge (17a) is formed in the locking portion (17). 
Uređaj (100; 100) u skladu s patentnim zahtjevima 3 ili 4, naznačen time, da je rub (17a) oblikovan u dijelu za blokiranje (17).
or a pharmaceutically acceptable salt or solvate thereof; wherein ring A is a heteroaryl ring selected from the group consisting of furanyl, thiazolyl, imidazothiazolyl and pyrazinyl; 
ili njegova farmaceutski prihvatljiva sol ili solvat; naznačen time da prsten A je heteroaril prsten odabran iz skupine koju čine furanil, tiazolil, imidazotiazolil i pirazinil;
In some embodiments, the inflammatory disease is of the small intestine, colon or rectum. 
Kompozicija za upotrebu prema zahtjevu 2, gdje je upalna bolest tankog crijeva, debelog crijeva ili rektuma.
Thermal polyurethane adhesives (so-called "hotmelts"), such as offered by the company Henkel, Germany, are applied in a hot form and must be quickly processed. 
Termička poliuretanska ljepila (tako zvane vruće otopine), takva kao što nudi kompanija Henkel, Njemačka, primjenjuju se u vrućem stanju i s njima se mora brzo raditi.
The make and break threaded connection of Claim 1, wherein the average thread height (h1, h2, h3, h4) of the pin threads is about 0.04 inches or greater. 
,Make and break" priključak s navojem iz zahtjeva 1, naznačen time da je prosječna visina navoja (hl, h2, h3, h4) klinastih navoja oko 0,04 inčeva ili veća.
Hence, in a preferred embodiment, the present composition contains at least 0.5% by weight of dry matter of pyrazine derivatives according to formula (I), wherein at least two of R1-R4 independently represent a hydroxyhydrocarbyl residue or an ester or an ether thereof. 
Prema tome, u poželjnom ostvarenju, sadašnji pripravak sadržava najmanje 0,5%, po masi suhe tvari, derivata pirazina prema formuli (I), gdje najmanje dva od R;-R, nezavisno predstavljaju hidroksihidrokarbilni ostatak ili njegov ester ili eter.
The composition of claim 1, the compound represented by a structure of Formula 3 or stereoisomer thereof or pharmaceutically acceptable salt thereof: 
u pg Sunnala Fuemalt 2 1, tvar sadrži strukturu Formule 3 ili njen stereoizomer ili njenu farmaceutski
EP 577 561 teaches a machine for delivering two brewed beverages (e.g. 
Dokument EP 577 561 poučava o stroju za istodobno pravljenje dva kuhana napitka (npr.
The compound of claim 1, wherein the compound has formula V 
Spoj sukladno zahtjevu 1, pri čemu je spoj formule V
for a machine that is stopped, by processing data from successive stored rows of data; 
za uređaj koji je zaustavljen, pomoću obrade podataka iz uzastopno pohranjenih redova podataka (Lp);
The method of claim 3, wherein the sodium hyaluronate or hyaluronic acid is present at a concentration of 500-5,000 ug/mL. 
Farmaceutski oblik za uporabu prema zahtjevu 5, gdje farmaceutski oblik sadrži natrijev hijaluronat ili hijaluronsku kiselinu u terapijski učinkovitoj koncentraciji od 500-5,000 ug/mL.
The use of compounds according to any of claims 1 to 13 for the preparation of medicaments for the treatment and/or prophylaxis of diabetes, non-insulin-dependent diabetes mellitus, impaired glucose tolerance, inflammatory bowel disease, Colitis Ulcerosa, Morbus Crohn, hypertension, diseases wherein a diuretic agent has a beneficial effect, obesity, and/or metabolic syndrome or B-cell protection. 
Uporaba spojeva prema bilo kojem od zahtjeva 1 do 13, naznačena time, da se primjenjuje za proizvodnju lijekova za liječenje i/ili profilaksu dijabetesa, diabetes mellitus neovisnog o inzulinu, oslabljene tolerancije glukoze, upalne bolesti crijeva, Colitis Ulcerosa, Morbus Crohn-ove bolesti, hipertenzije, bolesti kod koje diuretičko sredstvo ima blagotvoran učinak, gojaznosti, i/ili metaboličkog sindroma, ili za zaštitu B-stanica.
In other preferred embodiments of the invention, the adhesive is a hypoallergenic and pressure-sensitive contact adhesive. 
U drugim preferiranim uobličenjima izuma, ljepilo je hipoalergensko i na pritisak osjetljivo kontaktno ljepilo.
Method according to any of the preceding claims, wherein said selected preset position maximizes a probability of detecting an event in said area to be monitored. 
Postupak u skladu s patentnim zahtjevom 5, naznačen time, da navedena konfiguracija maksimizira vjerojatnost otkrivanja događaja u navedenoj zoni koja se nadzire.
The composition according to claim 13 for use in the treatment and/or prophylaxis of disorders and/or diseases selected from the group consisting of pain, preferably pain selected from the group consisting of acute pain, chronic pain, neuropathic pain, muscular pain, visceral pain and inflammatory pain, epilepsy, urinary incontinence, anxiety, dependency, mania, bipolar disorders, migraine, cognitive diseases and dystonia-associated dyskinesias. 
Pripravak prema zahtjevu 13 naznačen time da je za uporabu u liječenju i/ili sprječavanju poremećaja 1/ili bolesti koje se biraju iz skupine koju čine bol, poželjno bol koja se bira iz skupine koju čine akutna bol, kronična bol, neuropatska bol, bol u mišićima, visceralna bol i upalna bol, epilepsija, urimarna inkontinencija, anksioznost, ovisnost, manija, bipolarni poremećaj, migrena, kognitivni poremećaji 1 diskinezije povezane s distonijom.
In another aspect of the present invention the concentration of the homogeneous catalyst may be at least 0.5% by weight, such as at least 1% by weight, and preferably at least 1.5% by weight, such as at least 2.0% by weight, and even more preferably above 2.5% by weight, such as at least 4% by weight. 
Metoda u skladu s patentnim zahtjevom 52, pri čemu je koncentracija homogenog katalizatora najmanje 0,5 % prema težini, kao što je najmanje 1 % prema težini, a poželjno najmanje 1,5 % prema težini, kao što je najmanje 2,0 % prema težini, a još poželjnije iznad 2,5 % prema težini, kao što je najmanje 4 % prema težini.
Method according to claim 3, characterized in that, in the final processing of the ceramic part (A) its surface is treated with a gentle polishing action in the region where the modified surface is removed, and alternatively use ultrasonic bath, followed by a visual check the machined surface of the ceramic part (A). 
Postupak prema zahtjevu 3., naznačen time da se kod završne obrade keramičkog dijela (A) njegova površina tretira blagim poliranjem u području gdje je uklonjena modificirana površina, 1 alternativno upotrijebi ultrazvučna kupelj, poslije čega slijedi vizualna provjera obrađene površine keramičkog dijela (A).
A kit comprising a tissue targeting moiety selected from antibodies, antibody constructs, fragments of antibodies, constructs of fragments or a mixture thereof, peptide, amino acid, steroidal or non-steroidal hormone, folate, estrogen, testosterone or biotin, conjugated via a coupling moiety to an octadentate hydroxypyridinone-containing ligand of formula III or IV 
Komplet naznačen time da sadrži skupinu za ciljanje tkiva odabranu od protutijela, konstrukata protutijela, fragmenata protutijela, konstrukata fragmenata ili njihovih smjesa, peptida, aminokiseline, steroidnog ili nesteroidnog hormona, folata, estrogena, testosterona ili biotina, konjugiranu putem spojnog dijela na ligand koji sadrži oktadentat hidroksipiridinon s formulom III ili IV
By using the basic formulation of the sugar replacement composition of the second and third example, the amount of fat, i.e. 
Koristeći se osnovnom formulacijom za sastavine iz drugog i trećeg primjera, koja zamjenjuje šećer, može se količina masnoće, tj.
The compound as claimed in claim 1, which is selected from the group consisting of: 
Spoj prema zahtjevu 1, naznačen time da je odabran iz skupine koja sadrži:
Compounds of formulae II, III and IV or salts thereof are novel and form part of the invention. 
Spojevi formule II, III i TV ili njihove soli su novost i kao takvi čine dio izuma.
means for comparing a sequence of received symbols of each packet with a corresponding sequence of expected symbols for the same packet; and 
- = sredstvo za uspoređivanje sekvence zaprimljenih simbola (a;') svakog paketa s odgovarajućom sekvencom očekivanog simbola (a,) istog paketa; i
granulating the ibuprofen with a solution of tramadol, or one of the pharmaceutically acceptable salts thereof, and a binding agent, 
granuliranja ibuprofena s otopinom tramadola, ili jedne od njegovih farmaceutski prihvatljivih soli, i vezivnim sredstvom, sušenja granula,
The compound of claim 1 or a pharmaceutically acceptable salt thereof, wherein W, X, Y and Z are CH. 
Tvar iz patentnog zahtjeva 1, pri čemu su W, X, Y i Z jednaki CH.
The umbrella as recited in claim 1, wherein two respective adjoining umbrella strut elements are supported against each other at their respective contact surfaces. 
Kišobran kao što je navedeno u patentnom zahtjevu 1, naznačen time da su dva odgovarajuća susjedna potporna elementa kišobrana međusobno oslonjeni u njihovoj odgovarajućoj dodirnoj točki.